HUP0202204A2 - Synergic pharmaceutical composition - Google Patents

Synergic pharmaceutical composition

Info

Publication number
HUP0202204A2
HUP0202204A2 HU0202204A HUP0202204A HUP0202204A2 HU P0202204 A2 HUP0202204 A2 HU P0202204A2 HU 0202204 A HU0202204 A HU 0202204A HU P0202204 A HUP0202204 A HU P0202204A HU P0202204 A2 HUP0202204 A2 HU P0202204A2
Authority
HU
Hungary
Prior art keywords
alkyl
alkoxy
phenyl
composition containing
optionally
Prior art date
Application number
HU0202204A
Other languages
Hungarian (hu)
Inventor
Nagy Peter Dr Literati
Gyoergy Dr Rabloczky
Zoltan Dr Szilvassy
Original Assignee
N Gene Res Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N Gene Res Lab Inc filed Critical N Gene Res Lab Inc
Priority to HU0202204A priority Critical patent/HU226244B1/en
Priority to BR0210744-9A priority patent/BR0210744A/en
Priority to CA002682251A priority patent/CA2682251A1/en
Priority to PCT/HU2002/000067 priority patent/WO2003007951A1/en
Priority to DE60225143T priority patent/DE60225143T2/en
Priority to SI200230685T priority patent/SI1408966T1/en
Priority to CNB02814340XA priority patent/CN1270713C/en
Priority to MXPA04000324A priority patent/MXPA04000324A/en
Priority to ES02751454T priority patent/ES2300460T3/en
Priority to IL15941202A priority patent/IL159412A0/en
Priority to DK02751454T priority patent/DK1408966T3/en
Priority to PL364662A priority patent/PL205826B1/en
Priority to KR1020047000748A priority patent/KR100920560B1/en
Priority to RU2004105149/15A priority patent/RU2311907C2/en
Priority to CA002452558A priority patent/CA2452558C/en
Priority to JP2003513558A priority patent/JP4598390B2/en
Priority to AU2002354884A priority patent/AU2002354884B2/en
Priority to NZ531155A priority patent/NZ531155A/en
Priority to PT02751454T priority patent/PT1408966E/en
Priority to UA2004021166A priority patent/UA81608C2/en
Priority to EP02751454A priority patent/EP1408966B1/en
Priority to US10/495,240 priority patent/US7635674B2/en
Priority to AT02751454T priority patent/ATE386523T1/en
Publication of HU0202204D0 publication Critical patent/HU0202204D0/hu
Publication of HUP0202204A2 publication Critical patent/HUP0202204A2/en
Priority to IL159412A priority patent/IL159412A/en
Priority to NO20040153A priority patent/NO20040153L/en
Priority to CY20081100487T priority patent/CY1107939T1/en
Publication of HU226244B1 publication Critical patent/HU226244B1/en
Priority to US12/614,225 priority patent/US8048873B2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pharmaceutical combination, comprises: (A) a composition containing an antidiabetic or anti-hyperlipidemic agent (I); and (B) a composition containing a hydroximic acid derivative (II). Pharmaceutical combination, comprises: (A) a composition containing an antidiabetic or anti-hyperlipidemic agent (I); and (B) a composition containing a hydroximic acid derivative of formula (II). [Image] R 1>H or 1-5C alkyl; R 2>H, 1-5C alkyl, 3-8C cycloalkyl, phenyl, hydroxyphenyl or biphenylyl; R 3>H or a phenyl, naphthyl or pyridyl group (optionally substituted by halogen or 1-4C alkoxy); NR 1>R 2>5-8 membered ring (optionally containing further N, O or S heteroatoms and optionally fused to another alicyclic or heterocyclic ring, where N and/or S heteroatoms are optionally in oxide or dioxide form); Y : H, OH, 1-24C alkoxy (optionally substituted by amino), 2-24C polyalkenyloxy (with 1-6 double bonds), 1-25C alkanoyl, 3-9C alkenoyl or R 7>COO; R 7>2-24C polyalkenyl (with 1-6 double bonds); B : undefined; X : halo, amino or 1-4C alkoxy; or X+B : oxo; or X+Y : 1,2,4-oxadiazine or 4,5-dihydro-1,2,4-oxadiazine; R : H; A : 1-4C alkylene, a bond or (CHR 4>) m-(CHR 5>) n; R 4>H, 1-5C alkyl, 3-8C cycloalkyl or phenyl (optionally substituted by halo, 1-4C alkoxy or 1-5C alkyl); R 5>H, 1-4C alkyl or phenyl; and m, n : 0-2. ACTIVITY : Antidiabetic; Antilipemic. No biological data available. MECHANISM OF ACTION : None given.
HU0202204A 2001-07-17 2002-07-05 Pharmaceutical combination for the prophylaxis or treatment of diabetes HU226244B1 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
HU0202204A HU226244B1 (en) 2002-07-05 2002-07-05 Pharmaceutical combination for the prophylaxis or treatment of diabetes
RU2004105149/15A RU2311907C2 (en) 2001-07-17 2002-07-10 Synergetic pharmaceutical composition for prophylaxis and treatment of diabetes mellitus
AU2002354884A AU2002354884B2 (en) 2001-07-17 2002-07-10 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
JP2003513558A JP4598390B2 (en) 2001-07-17 2002-07-10 Synergistic pharmaceutical composition for diabetes prevention or treatment
DE60225143T DE60225143T2 (en) 2001-07-17 2002-07-10 SYNERGISTIC PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OR PROPHYLAXIS OF DIABETES
CA002682251A CA2682251A1 (en) 2001-07-17 2002-07-10 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
CNB02814340XA CN1270713C (en) 2001-07-17 2002-07-10 Synergistic pharmaceutical combination for prevention or treatment of diabetes
MXPA04000324A MXPA04000324A (en) 2001-07-17 2002-07-10 A synergistic pharmaceutical combination for the prevention or treatment of diabetes.
ES02751454T ES2300460T3 (en) 2001-07-17 2002-07-10 PHARMACEUTICAL SYNERGIC COMBINATIONS INTENDED FOR THE PREVENTION OR TREATMENT OF DIABETES.
IL15941202A IL159412A0 (en) 2001-07-17 2002-07-10 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
DK02751454T DK1408966T3 (en) 2001-07-17 2002-07-10 Synergistic pharmaceutical combinations for the prevention or treatment of diabetes
PL364662A PL205826B1 (en) 2001-07-17 2002-07-10 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
NZ531155A NZ531155A (en) 2001-07-17 2002-07-10 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
BR0210744-9A BR0210744A (en) 2001-07-17 2002-07-10 Synergistically Pharmaceutical Combination for the Prevention or Treatment of Diabetes
CA002452558A CA2452558C (en) 2001-07-17 2002-07-10 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
PCT/HU2002/000067 WO2003007951A1 (en) 2001-07-17 2002-07-10 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
SI200230685T SI1408966T1 (en) 2001-07-17 2002-07-10 Synergistic pharmaceutical combinations for the prevention or treatment of diabetes
KR1020047000748A KR100920560B1 (en) 2001-07-17 2002-07-10 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
PT02751454T PT1408966E (en) 2001-07-17 2002-07-10 Synergistic pharmaceutical combinations for the prevention or treatment of diabetes
UA2004021166A UA81608C2 (en) 2002-07-05 2002-07-10 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
EP02751454A EP1408966B1 (en) 2001-07-17 2002-07-10 Synergistic pharmaceutical combinations for the prevention or treatment of diabetes
US10/495,240 US7635674B2 (en) 2001-07-17 2002-07-10 Synergistic pharmaceutical combination for the prevention or treatment of diabetes
AT02751454T ATE386523T1 (en) 2001-07-17 2002-07-10 SYNERGISTIC PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OR PROPHYLAXIS OF DIABETES
IL159412A IL159412A (en) 2001-07-17 2003-12-17 Synergistic pharmaceutical combination for the prevention or treatment of diabetes
NO20040153A NO20040153L (en) 2001-07-17 2004-01-13 Synergistic pharmaceutical combination for prophylaxis or treatment of diabetes
CY20081100487T CY1107939T1 (en) 2001-07-17 2008-05-08 SYNOPTIC MEDICINAL DRUGS FOR PREVENTION OR TREATMENT OF DIABETES
US12/614,225 US8048873B2 (en) 2001-07-17 2009-11-06 Synergistic pharmaceutical combination for the prevention or treatment of diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0202204A HU226244B1 (en) 2002-07-05 2002-07-05 Pharmaceutical combination for the prophylaxis or treatment of diabetes

Publications (3)

Publication Number Publication Date
HU0202204D0 HU0202204D0 (en) 2002-09-28
HUP0202204A2 true HUP0202204A2 (en) 2003-05-28
HU226244B1 HU226244B1 (en) 2008-07-28

Family

ID=89980598

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202204A HU226244B1 (en) 2001-07-17 2002-07-05 Pharmaceutical combination for the prophylaxis or treatment of diabetes

Country Status (2)

Country Link
HU (1) HU226244B1 (en)
UA (1) UA81608C2 (en)

Also Published As

Publication number Publication date
UA81608C2 (en) 2008-01-25
HU0202204D0 (en) 2002-09-28
HU226244B1 (en) 2008-07-28

Similar Documents

Publication Publication Date Title
IL150565A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
NZ502209A (en) Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
IL128690A0 (en) Cyclic amine derivatives pharmaceutical compositions containing the same and use thereof
NO951044L (en) Selective antagonist compounds for human -NK3 receptor and their use as drugs and diagnostic agents
EE05103B1 (en) Pharmaceutical formulations containing azetidine derivatives, azetidine derivatives and methods for their preparation
WO2004082581A3 (en) Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof
NO304113B1 (en) Crystalline thiagabine hydrochloride monohydrate, pharmaceutical composition comprising it, and use thereof for the manufacture of a medicament
AU4950593A (en) 2, 6-dihydroxy phenyl propanionic acid derivatives, process for their production and their use as pharmaceutical agents
HUP0402282A2 (en) Triazolo[1,5a] quinoline derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0202204A2 (en) Synergic pharmaceutical composition
FI945412A (en) Alcohols as potassium channel openers and in the treatment of urinary incontinence
PH25532A (en) Novel n-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives, pharm,aceutical composition containing said compound, method of use thereof
GR3035371T3 (en) Benzyloxy-substituted phenylglycinolamides as pharmaceutical agents
US6471948B1 (en) Toothpaste compositions containing cetylpyridinium chloride
DE59002880D1 (en) CRYSTALLINE CEPHEM ACID ADDITION SALTS AND METHOD FOR THE PRODUCTION THEREOF.
AU1649088A (en) New spiro (4,5) decane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them
AU4842297A (en) New N-benzylpiperazine compounds, process for their preparation and the pharmaceutical compositions which contain them
HK57297A (en) Morpholine derivatives their process of preparation and pharmaceutical compositions containing them
NZ512891A (en) S-oxide lipid lowering compounds
ES8202828A1 (en) Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application.
BR0307468A (en) Antimicrobial Thiadiazinone Derivatives Useful in the Treatment of Bacterial Infections
AU1266097A (en) New pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions containing them
BR0007729A (en) Compound, pharmaceutical composition, and methods of controlling bacterial infections in a host in need of such therapy, and preparation of a compound
HUP9701381A2 (en) New 7,8-dihydro-8,8-disubstituted-9h-1,3-dioxolo-[4,5-h][2,3]-benzodiazepine derivatives, pharmaceutical compositions containing them as active component, and process for producing them
HUP9701380A2 (en) New 8-substituted-9h-1,3-dioxolo-[4,5-h][2,3]-benzodiazepine derivatives, pharmaceutical compositions containing them as active component, and process for producing them

Legal Events

Date Code Title Description
NF4A Restoration of patent protection
MM4A Lapse of definitive patent protection due to non-payment of fees